Latest Period
Q2 2026
Security Snapshot
BICYCLE THERAPEUTICS PLC - American Depositary Shares, each representing one ordinary share, nominal value 0.01 euro per share (BCYC) Institutional Ownership
CUSIP: 088786108
13F Institutional Holders and Ownership History from Q2 2019 to Q2 2026
Institutions Reporting
104
Shares (Excl. Options)
37,256,063
Price
$4.24
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / American Depositary Shares, each representing one ordinary share, nominal value 0.01 euro per share
- Symbol
- BCYC on Nasdaq
- All holders as of 30 Jun 2026
- Q2 2026
- Total 13F shares
- 37,256,063
- Total 13F value
- $157,883,182
- Portfolio coverage rank
- 0%
- Share change
- -203,768
- Value change
- -$2,311,131
- Number of holders
- 104
- Shares outstanding
- 50,565,476
- SEC-reported price per share
- $4.21
- Insider filing price
- $4.21
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- BCYC - BICYCLE THERAPEUTICS PLC - American Depositary Shares, each representing one ordinary share, nominal value 0.01 euro per share is tracked under CUSIP 088786108.
- 104 institutions reported positions in Q2 2026.
- 6 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 98 to 104 between Q1 2026 and Q2 2026.
- SEC-reported value moved from $173,587,357 to $157,883,182.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 104 institutions filings for Q2 2026.
Security key
088786108
Latest holder period
Q2 2026
13F holders
104
13D/G owners
6
CIK / CUSIP context first
Open Q2 2026 holders
BCYC full holder history
BICYCLE THERAPEUTICS PLC SEC filings
BICYCLE THERAPEUTICS PLC company facts
BICYCLE THERAPEUTICS PLC insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 088786108:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
6
Security
BCYC
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Forbion Growth Opportunities Fund II Cooperatief U.A. | 7.3% | $28,343,629 | 3,452,330 | Forbion Growth Opportunities Fund II Cooperatief U.A. | 21 Nov 2024 | |||
| ARMISTICE CAPITAL, LLC | 6.7% | -0.43% | $14,543,440 | 3,398,000 | 0% | Armistice Capital, LLC | 30 Jun 2026 | |
| Long Focus Capital Management, LLC | 6.6% | $16,487,221 | 3,310,687 | LONG FOCUS CAPITAL MANAGEMENT, LLC | 31 Mar 2026 | |||
| Point72 Asset Management, L.P. | 3.9% | -49% | $14,882,536 | -$15,032,008 | 1,860,317 | -50% | Point72 Asset Management, L.P. | 30 Jun 2025 |
| Invus Global Management, LLC | 3.1% | -53% | $7,773,192 | -$7,909,072 | 1,560,882 | -50% | Raymond Debbane | 31 Mar 2026 |
| Deep Track Capital, LP | 2.4% | -54% | $9,625,952 | -$12,943,416 | 1,203,244 | -57% | Deep Track Capital, LP | 30 Jun 2025 |
As of 30 Jun 2026, 104 institutional investors reported holding 37,256,063 shares of BICYCLE THERAPEUTICS PLC - American Depositary Shares, each representing one ordinary share, nominal value 0.01 euro per share (BCYC). This represents 74% of the company’s total 50,565,476 outstanding shares.
13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
68%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| BAKER BROS. ADVISORS LP | 22% | 10,885,357 | 0% | 0.23% | $46,153,914 |
| FCPM III SERVICES B.V. | 6.9% | 3,468,430 | 0% | 2% | $14,706,143 |
| ARMISTICE CAPITAL, LLC | 6.7% | 3,398,000 | 0% | 0.4% | $14,407,520 |
| Long Focus Capital Management, LLC | 6.5% | 3,310,687 | 0% | 0.58% | $14,037,313 |
| ACADIAN ASSET MANAGEMENT LLC | 3.9% | 1,968,025 | 0% | 0.01% | $8,319,000 |
| RENAISSANCE TECHNOLOGIES LLC | 3% | 1,533,400 | +57% | 0.01% | $6,501,616 |
| GSK plc | 3% | 1,529,561 | 0% | 1.1% | $6,485,339 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 1.8% | 902,150 | -12% | 0% | $3,826,000 |
| MARSHALL WACE, LLP | 1.6% | 797,940 | +111% | 0% | $3,383,266 |
| Qube Research & Technologies Ltd | 1.5% | 775,567 | +151% | 0% | $3,288,404 |
| MORGAN STANLEY | 1.3% | 667,269 | +7.9% | 0% | $2,829,221 |
| SCHRODER INVESTMENT MANAGEMENT GROUP | 1.2% | 615,833 | 0% | 0% | $2,555,707 |
| CITADEL ADVISORS LLC | 1.1% | 554,225 | +47% | 0% | $2,349,914 |
| MILLENNIUM MANAGEMENT LLC | 1.1% | 553,967 | +95% | 0% | $2,348,820 |
| Peapod Lane Capital LLC | 1.1% | 537,978 | +344% | 1.5% | $2,281,027 |
| DIADEMA PARTNERS LP | 0.92% | 462,724 | -2.9% | 0.74% | $1,961,950 |
| TWO SIGMA INVESTMENTS, LP | 0.86% | 434,577 | +164% | 0% | $1,842,606 |
| JANE STREET GROUP, LLC | 0.78% | 392,163 | +80% | 0% | $1,662,771 |
| Birchview Capital, LP | 0.62% | 313,616 | -32% | 0.62% | $1,329,732 |
| BlackRock, Inc. | 0.55% | 280,386 | +0.5% | 0% | $1,188,837 |
| MOORE CAPITAL MANAGEMENT, LP | 0.54% | 275,000 | 0% | 0.03% | $1,166,000 |
| Rangeley Capital, LLC | 0.5% | 253,500 | +9.1% | 1.1% | $1,074,840 |
| Palo Alto Investors LP | 0.4% | 201,890 | 0% | 0.12% | $856,014 |
| Sculptor Capital LP | 0.39% | 197,904 | 0.01% | $839,113 | |
| Eversept Partners, LP | 0.38% | 190,715 | 0% | 0.04% | $808,632 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
29
Latest
Q2 2026
Rows shown
1-25 of 29
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q2 | 37,256,063 | $157,883,182 | -$2,311,131 | $4.24 | 104 |
| 2026 Q1 | 37,459,831 | $173,587,357 | -$22,803,169 | $4.64 | 98 |
| 2025 Q4 | 39,173,346 | $277,662,853 | +$3,442,632 | $7.08 | 109 |
| 2025 Q3 | 36,906,185 | $285,619,779 | -$29,768,237 | $7.74 | 99 |
| 2025 Q2 | 41,200,406 | $286,338,478 | -$7,404,258 | $6.95 | 110 |
| 2025 Q1 | 41,735,285 | $354,350,748 | -$8,366,393 | $8.49 | 95 |
| 2024 Q4 | 41,890,221 | $586,472,317 | -$21,543,705 | $14.00 | 96 |
| 2024 Q3 | 40,439,351 | $915,266,321 | +$21,080,974 | $22.63 | 104 |
| 2024 Q2 | 39,722,044 | $803,959,492 | +$167,237,644 | $20.24 | 105 |
| 2024 Q1 | 30,475,266 | $758,677,656 | +$6,974,793 | $24.90 | 93 |
| 2023 Q4 | 31,374,408 | $567,252,558 | -$28,664,876 | $18.08 | 98 |
| 2023 Q3 | 32,418,922 | $651,281,538 | +$165,201,151 | $20.09 | 101 |
| 2023 Q2 | 24,236,173 | $618,449,426 | +$18,484,148 | $25.52 | 84 |
| 2023 Q1 | 23,558,818 | $498,895,905 | -$47,151,037 | $21.27 | 89 |
| 2022 Q4 | 23,577,228 | $697,847,861 | +$39,624,167 | $29.60 | 87 |
| 2022 Q3 | 23,196,999 | $539,598,338 | +$13,911,506 | $23.26 | 77 |
| 2022 Q2 | 22,709,672 | $381,075,755 | -$69,885,312 | $16.78 | 78 |
| 2022 Q1 | 20,168,148 | $884,247,452 | -$137,175,184 | $43.88 | 100 |
| 2021 Q4 | 21,550,279 | $1,311,636,981 | +$387,558,387 | $60.87 | 98 |
| 2021 Q3 | 14,210,499 | $591,072,741 | +$80,484,868 | $41.59 | 67 |
| 2021 Q2 | 12,412,613 | $376,901,461 | +$30,169,498 | $30.36 | 53 |
| 2021 Q1 | 11,420,830 | $341,203,000 | +$123,064,104 | $29.87 | 39 |
| 2020 Q4 | 7,328,435 | $131,544,000 | -$3,975,466 | $17.95 | 27 |
| 2020 Q3 | 7,550,163 | $143,830,000 | +$24,085,212 | $19.05 | 18 |
| 2020 Q2 | 6,287,737 | $98,861,000 | +$4,298,929 | $15.74 | 15 |